Bank of Nova Scotia’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.8M Sell
1,238,830
-71,557
-5% -$2.11M 0.07% 221
2026
Q1
$36.3M Sell
1,310,387
-112,613
-8% -$2.89M 0.06% 218
2025
Q4
$30.9M Buy
+1,423,000
New +$28.1M 0.05% 267
2023
Q4
Sell
-978,315
Closed -$11.4M 1074
2023
Q3
$11.4M Buy
+978,315
New +$11.1M 0.03% 298

Other funds holding ROIV

Bank of Nova Scotia's ROIV Position: Q2 2026 in Review

Bank of Nova Scotia reduced its Roivant Sciences (ROIV) stake by 5.5% in Q2 2026, selling an estimated $2.11M and leaving 1,238,830 shares worth $43.8M. The position accounts for 0.07% of the portfolio, ranked #221.

Bank of Nova Scotia first reported a position in ROIV in Q3 2023 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Bank of Nova Scotia held 1,238,830 shares of Roivant Sciences worth $43.8M as of Q2 2026.
  • Bank of Nova Scotia sold 71,557 Roivant Sciences shares in Q2 2026, an estimated $2.11M.
  • Roivant Sciences made up 0.07% of Bank of Nova Scotia's portfolio in Q2 2026, its #221 holding.
  • Bank of Nova Scotia first reported a position in Roivant Sciences in Q3 2023 and has held it in 4 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.